BEONE MEDICINES LTD. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
BEONE MEDICINES LTD. (ONC) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent of $27.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $27.88M, a 2.33% decline year-over-year.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $24.47M, a 279.91% increase year-over-year.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $22.25M.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $12.06M, a 78.75% decline year-over-year.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2025 was $69.30M.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2024 was -$47.56M.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2023 was -$25.46M.
- BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2022 was -$90.42M.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.88M 10-Q · filed 2026-08-05 | $52.35M 10-Q · filed 2026-08-05 | $74.61M derived: sum of 3 quarters · filed 2026-08-05 | $86.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $24.47M 10-Q · filed 2026-05-06 | $46.72M derived: sum of 2 quarters · filed 2026-05-06 | $58.78M derived: sum of 3 quarters · filed 2026-05-06 | $87.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $22.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.31M derived: sum of 2 quarters · filed 2026-02-26 | $62.86M derived: sum of 3 quarters · filed 2026-08-05 | $69.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $12.06M 10-Q · filed 2025-11-06 | $40.60M derived: sum of 2 quarters · filed 2026-08-05 | $47.05M 10-Q · filed 2025-11-06 | -$15.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $28.55M 10-Q · filed 2026-08-05 | $34.99M 10-Q · filed 2026-08-05 | -$27.93M derived: sum of 3 quarters · filed 2026-08-05 | $28.82M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $6.44M 10-Q · filed 2026-05-06 | -$56.47M derived: sum of 2 quarters · filed 2026-05-06 | $275.00K derived: sum of 3 quarters · filed 2026-05-06 | -$8.96M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$62.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.17M derived: sum of 2 quarters · filed 2026-02-26 | -$15.40M derived: sum of 3 quarters · filed 2026-02-26 | -$47.56M 10-K · filed 2026-02-26 |
| 2024-09-30 | $56.75M 10-Q · filed 2025-11-06 | $47.51M derived: sum of 2 quarters · filed 2025-11-06 | $15.35M 10-Q · filed 2025-11-06 | $65.62M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$9.24M 10-Q · filed 2025-08-06 | -$41.40M 10-Q · filed 2025-08-06 | $8.87M derived: sum of 3 quarters · filed 2026-02-26 | $6.31M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$32.16M 10-Q · filed 2025-05-07 | $18.11M derived: sum of 2 quarters · filed 2026-02-26 | $15.55M derived: sum of 3 quarters · filed 2026-02-26 | -$70.97M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $50.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.71M derived: sum of 2 quarters · filed 2026-02-26 | -$38.81M derived: sum of 3 quarters · filed 2026-02-26 | -$25.46M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$2.56M 10-Q · filed 2024-11-12 | -$89.08M derived: sum of 2 quarters · filed 2024-11-12 | -$75.73M 10-Q · filed 2024-11-12 | $2.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$86.52M 10-Q · filed 2024-08-07 | -$73.17M 10-Q · filed 2024-08-07 | $4.82M derived: sum of 3 quarters · filed 2025-02-27 | -$75.51M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $13.35M 10-Q · filed 2023-05-04 | $91.34M derived: sum of 2 quarters · filed 2025-02-27 | $11.01M derived: sum of 3 quarters · filed 2025-02-27 | -$86.45M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $77.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.34M derived: sum of 2 quarters · filed 2025-02-27 | -$99.80M derived: sum of 3 quarters · filed 2025-02-27 | -$90.42M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$80.33M 10-Q · filed 2023-11-09 | -$177.78M derived: sum of 2 quarters · filed 2023-11-09 | -$168.41M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$97.46M 10-Q · filed 2023-08-02 | -$88.08M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $9.37M 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $664.00K 10-Q · filed 2022-11-09 | $10.29M derived: sum of 2 quarters · filed 2022-11-09 | $6.53M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $9.63M 10-Q · filed 2022-08-08 | $5.86M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$3.76M 10-Q · filed 2022-05-09 |